Intuitive Surgical, Inc. $ISRG Shares Acquired by RPG Investment Advisory LLC

Key Points

• RPG Investment Advisory LLC has significantly increased its holdings in Intuitive Surgical, Inc. by 106.5%, now owning 65,440 shares valued at approximately $32.41 million.
• Analysts have raised their price targets for Intuitive Surgical, with new targets from Citigroup at $650.00 and other firms adjusting theirs upward, reflecting positive market sentiment.
• Insider transactions reveal significant stock sales, including a 92.73% decrease in one executive's position, amidst a backdrop where insiders have sold a total of 15,839 shares recently.

RPG Investment Advisory LLC raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 106.5% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 65,440 shares of the medical equipment provider's stock after purchasing an additional 33,750 shares during the quarter. Intuitive Surgical accounts for approximately 2.3% of RPG Investment Advisory LLC's portfolio, making the stock its 13th largest position. RPG Investment Advisory LLC's holdings in Intuitive Surgical were worth $32,410,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Chilton Capital Management LLC raised its position in Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 43 shares during the period. Parvin Asset Management LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth $26,000. Global Financial Private Client LLC increased its position in shares of Intuitive Surgical by 253.3% during the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after acquiring an additional 38 shares during the period. Elite Financial Inc. purchased a new stake in shares of Intuitive Surgical during the first quarter worth $26,000. Finally, LFA Lugano Financial Advisors SA purchased a new stake in shares of Intuitive Surgical during the first quarter worth $30,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Trading Up 1.3%

NASDAQ:ISRG traded up $6.28 during trading hours on Friday, hitting $476.16. The company's stock had a trading volume of 2,023,902 shares, compared to its average volume of 1,980,700. The stock has a market capitalization of $170.69 billion, a P/E ratio of 66.41, a price-to-earnings-growth ratio of 4.99 and a beta of 1.59. The stock has a fifty day moving average of $504.42 and a 200-day moving average of $521.12. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. During the same quarter in the prior year, the company posted $1.78 earnings per share. Intuitive Surgical's revenue for the quarter was up 21.4% compared to the same quarter last year. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of the company's stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the transaction, the executive vice president owned 353 shares in the company, valued at $173,845.44. This represents a 92.73% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Gary S. Guthart sold 7,893 shares of the company's stock in a transaction on Monday, July 28th. The shares were sold at an average price of $498.64, for a total transaction of $3,935,765.52. Following the completion of the transaction, the insider owned 13,187 shares of the company's stock, valued at $6,575,565.68. This represents a 37.44% decrease in their position. The disclosure for this sale can be found here. Insiders sold 15,839 shares of company stock worth $7,896,972 over the last 90 days. Corporate insiders own 0.70% of the company's stock.

Analysts Set New Price Targets

A number of research firms have recently weighed in on ISRG. Zacks Research lowered Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research report on Wednesday. Wells Fargo & Company upped their price objective on Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a research report on Wednesday, July 23rd. BTIG Research upped their price objective on Intuitive Surgical from $566.00 to $571.00 and gave the stock a "buy" rating in a research report on Wednesday, July 23rd. Wall Street Zen raised Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Saturday, July 26th. Finally, Deutsche Bank Aktiengesellschaft lowered Intuitive Surgical from a "hold" rating to a "sell" rating and cut their price objective for the stock from $515.00 to $440.00 in a research report on Monday, June 9th. Thirteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Intuitive Surgical presently has an average rating of "Moderate Buy" and a consensus price target of $595.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.